READ: Featured Drug Insights: October 2025 - Prime Therapeutics
READ: Featured Drug Insights: October 2025
Your source for all Prime Therapeutics' October 2025 Drug Insights publications.
Prime Therapeutics (Prime) provides you with regular updates on the drug pipeline as well as next-generation clinical information and hot topics. The following Drug Insights publications for October 2025 will keep you informed on what’s trending now and trending clinical topics.
Released Oct. 9, 2025
A monthly report of the most notable drugs that may significantly affect the populations we serve. Drug highlights this month are etuvetidigene autotemcel, onasemnogene abeparvovec and more.
Released Oct. 13, 2025
FDA Decisions Expected: November 2025
A breakdown of FDA decisions expected of new drugs anticipated to hit the market, this edition covers plozasiran, sibeprenlimab, and more.
Released Oct. 15, 2025
Providing a clinical deep dive into a select high-cost drug in the pipeline, this month's profile features Etuvetidigene autotemcel intravenous (IV), a gene therapy to restore WAS protein (WASP) expression.
Released Oct. 21, 2025
Featuring commentary by Abby Kim, PharmD, BCOP, on developments in the oncology space, this installment explores innovations driving the future of breast cancer care in recognition Breast Cancer Awareness Month.
Released Oct. 30, 2025
Prime provides a quarterly drug pipeline report of anticipated new drugs, deep dives and indications for the following pipelines: traditional, specialty drugs, biosimilars, and gene and cell therapy.
Released Oct. 30, 2025
Dive into clinical insights and competitive intelligence on anticipated drugs in development, so you are well-sourced on the drug pipeline.
Released Sept. 30, 2025
Trending Topics & Drug Approvals: October 2025
We've combined Clinical Highlights and Drug Approvals into this new, monthly publication, which covers the latest specialty and traditional drug approvals. The latest edition features an update on COVID-19 vaccine guidance.
Looking for previous 2025 drug insights publications?
Simply click on the month to access past editions of our drug insights.